Mehrdad Ferdowsian, DO
Emergency Medicine · Henderson, NVNPI 1265530570
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,880 of the $9,082 with a category attached, or 86.8%. It is spread thinly across 38 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $38.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Biohaven Pharmaceuticals, Inc.$1K
- AstraZeneca$607
- Penumbra, Inc.$512
- Novo Nordisk$458
- Amgen$415
- plus $5K from 32 others
Across 7 payments — averaging $1708.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$11K
- Lucid Diagnostics Inc.$500
What the payments were for
- Consulting fees$1,20013%
- Food & beverage$7,88087%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 44 | $1,339 |
| Biohaven Pharmaceuticals, Inc. | 2 | $1,206 |
| AstraZeneca | 13 | $607 |
| Penumbra, Inc. | 4 | $512 |
| Novo Nordisk | 27 | $458 |
| Amgen(2 entities) | 15 | $415 |
| Boehringer Ingelheim | 19 | $374 |
| Intra-sana Laboratories | 4 | $323 |
| Medtronic(2 entities) | 4 | $311 |
| Nevro Corp. | 3 | $293 |
| Lilly USA, LLC | 13 | $280 |
| Lucid Diagnostics Inc. | 8 | $270 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $235 |
| AbbVie | 2 | $226 |
| Pfizer | 13 | $224 |
| Phathom Pharmaceuticals, Inc. | 6 | $215 |
| Forte Bio-pharma LLC | 2 | $199 |
| Bayer | 7 | $182 |
| Boston Scientific | 3 | $146 |
| Axsome Therapeutics, Inc. | 2 | $144 |
| Astellas Pharma US Inc | 1 | $125 |
| Asahi Intecc USA, Inc. | 1 | $123 |
| Johnson & Johnson | 1 | $123 |
| Daiichi Sankyo Inc. | 6 | $115 |
| Exact Sciences | 7 | $112 |
| W. L. Gore & Associates, Inc. | 1 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $74 |
| Dexcom, Inc. | 4 | $69 |
| Genentech USA, Inc. | 3 | $55 |
| GSK | 3 | $44 |
| Medline Industries LP | 1 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Merck | 2 | $31 |
| Amarin Pharma, Inc. | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- Indigo$507
- FreeStyle Libre 2$438
- Prolate$398
- Reltone 200 Mg$320
- GLYCATE$320
- Reltone 400 Mg$320
- PROCLAIM$289
- FARXIGA$231
- QULIPTA$226
- FREESTYLE LIBRE 3$215
- Axium$150
- Omnia$143
- Senza$138
- TANLOR$133
- Nalocet$133
- CAPLYTA$127
- Penumbra System$127
- Veozah$125
- BRILINTA$125
How this compares
$9,082 in reported general payments places this provider in the 95th percentile of 454 emergency medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 15 | $14,299 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $12,345 |
| FarxigaDapagliflozin Propanediol | 17 | $9,178 |
| Repatha SureclickEvolocumab | 12 | $6,671 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,487 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $885 |
| Atorvastatin Calcium | 95 | $559 |
| Omeprazole | 22 | $319 |
| Losartan Potassium | 38 | $280 |
| Metformin Hcl | 36 | $258 |
| Amlodipine Besylate | 38 | $246 |
| Tamsulosin Hcl | 15 | $246 |
| Gabapentin | 12 | $244 |
| Lisinopril | 43 | $237 |
| Hydrochlorothiazide | 31 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $280 | $14,29915 claims |
| MerckJanumet | $31 | $12,34511 claims |
| AstraZenecaFarxiga | $607 | $9,17817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 454 emergency medicine providers in Nevada.
Other emergency medicine in Henderson
- Jason KimHenderson$423
- Roger MartinezHenderson$334
- Daniel InglishHenderson$326
- Jason KatzHenderson$299
- Tim KuoHenderson$248
- Dana TrippiLas Vegas$305K
- Kevin BrownReno$30K
- Heidi KablerLas Vegas$19K
- Christopher NevarezNorth Las Vegas$13K
- Cornell CalinescuLas Vegas$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.